GlassScriptPhysician profile
Iradj Sharim
NPI 1790739423
$4,842.70
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,555 · 2020: $1,288.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $585.56 | 2019-2020 | |
| Amgen INC. | $532.01 | 2019-2020 | |
| Abbvie INC. | $517.35 | 2019-2020 | |
| Glaxosmithkline, LLC. | $373.40 | 2019-2020 | |
| Novo Nordisk INC | $330.38 | 2019 | |
| Allergan, INC. | $321.27 | 2019-2020 | |
| Lilly USA, LLC | $267.09 | 2019-2020 | |
| Amarin Pharma, INC. | $261.16 | 2019 | |
| Pfizer INC. | $256.92 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $226.61 | 2019 | |
| Novartis Pharmaceuticals Corporation | $208.37 | 2019 | |
| Avanir Pharmaceuticals, INC. | $188.58 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.76 | 2019 | |
| Genentech USA, INC. | $130.47 | 2019-2020 | |
| Valeritas, INC. | $125.00 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $88.65 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $85.12 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $71.01 | 2019 | |
| Si-Bone, INC. | $66.09 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.61 | 2019 | |
| Medtronic Minimed, INC. | $13.53 | 2019 | |
| Merck Sharp & Dohme LLC | $13.18 | 2019 | |
| Daiichi Sankyo INC. | $12.58 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iradj Sharim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.